SCOTTSDALE, Ariz., May 18, 2022 /PRNewswire/ — The Association of Marketing and Communication Professionals has named Amendola, a nationally recognized, award-winning healthcare and health IT public relations and marketing agency, as a Gold Winner in the 2022 Hermes Creative Awards competition. Amendola earned the award in the Strategic Campaigns category for a thought leadership program the agency executed on behalf of value-based care (VBC) administration pioneer HSBlox.
In a VBC system, providers such as hospitals and doctors are paid by health insurers based on patient outcomes rather than the current “fee-for-service” model. Ultimately, payers reward medical providers for helping patients become healthier.
The award-winning thought leadership campaign, which ran from February 2021 through February 2022, focused on raising awareness of data and payment exchange challenges—and solutions—associated with VBC models. Specifically, the program illustrated how HSBlox technology enables timely payment of services to social services agencies.
Amendola built a weekly cadence of media campaigns that included proactive, issues-based media pitching, company news and general thought leadership. Amendola successfully crafted new, creative story angles for media around emerging VBC models and secured briefings with top analyst firms covering payer markets.
The campaign yielded impressive results, including 17 briefings with eight analyst firms, 19 pieces of vendor-neutral content placed in high-value media outlets and five podcast appearances.
“The value-based care landscape is a crowded, competitive market that makes it difficult for any one player to stand out,” agency CEO Jodi Amendola explained. “To set HSBlox apart, we targeted analysts and publications focused on value-based care and health equity and positioned HSBlox as an innovator and valued resource.”
HSBlox solutions assist healthcare stakeholders at the intersection of value-based care and precision health with a secure, information-rich approach to event-based, patient-centric digital healthcare processes—empowering whole health in traditional care settings, the home and in the community.
“Our team’s work armed HSBlox’s sales leaders with high-value content to help move prospects through the sales funnel by underscoring the value of their digital infrastructure for success in a value-based care environment,” Amendola said.
AMCP’s Hermes Creative Awards is an international competition for creative professionals involved in the concept, writing and design of traditional and emerging media. AMCP consists of several thousand marketing, communication, advertising, public relations and digital media professionals.
About Amendola
Amendola is an award-winning, insights-driven public relations and marketing firm that integrates media relations, social media, content and lead gen programs to move healthcare, health IT and life sciences decision-makers to action. The agency represents some of the industry’s best-known brands as well as groundbreaking startups that are disrupting the status quo. Nearly 90% of its client base represents multi-year clients and/or repeat client executives. Amendola’s seasoned team of PR and marketing pros understand the ongoing complexities of the healthcare ecosystem and provide strategic guidance and creative direction to drive positive ROI, boost reputation and increase market share. Making an impact since 2003, Amendola combines traditional and digital media to fuel meaningful and measurable growth. For more information about the industry’s “A-Team,” visit www.acmarketingpr.com, and follow us on Twitter and LinkedIn.
Media contact:
Marcia Rhodes
MRhodes@acmarketingpr.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/amendola-nabs-hermes-creative-award-for-hsblox-thought-leadership-campaign-301549796.html
SOURCE Amendola Communications
Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…
AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…
Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…
Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…